JP Tillement

Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1‐acid glycoprotein.

Françoise Hervé, Emmanuel Gomas, JC Duche et al. · British Journal of Clinical Pharmacology · 1993 · 79 citations · Full text

Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity.

J. Barré, Ariane Mallat, Jean Rosenbaum et al. · British Journal of Clinical Pharmacology · 1987 · 53 citations · Full text

Severe Cirrhosis, Hepatology, Alcoholic Cirrhosis +15

The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.

Georges Houin, Felix Brunner, T Nebout et al. · British Journal of Clinical Pharmacology · 1983 · 38 citations · Full text

Plasma Half-life, Renal Function, Medicine +13

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer.

JC Duche, J. Barré, Hubert de Crémoux et al. · British Journal of Clinical Pharmacology · 1991 · 28 citations · Full text

Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.

Roland Zini, Didier Morin, C. Salvadori et al. · British Journal of Clinical Pharmacology · 1990 · 22 citations · Full text

Glycobiology, Tianeptine Fu, Pharmacokinetics +22